Phenotypic and Functional Characterization of CD8+ T Regulatory Cells

Methods in Molecular Biology

Volumn 677, Issue , 2011, Pages 63-83

  Ménoret, Séverine ^a,b,c,d   Guillonneau, Carole ^a,b,c   Bezié, Séverine ^a,b,c   Caron, Lise ^a,b,c   Anegon, Ignacio ^a,b,c   Li, Xian Liang ^a,b,c  

^a INSERM   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ DE NANTES   (France)

^d CNRS   (France)

Author keywords

CD4+ effector T cells; CD8+ regulatory T cells; CFSE; Dendritic cells; Suppressive function; Transwell analysis

Indexed keywords

INTERLEUKIN 2 RECEPTOR ALPHA;

ANIMAL; ARTICLE; CD8+ T LYMPHOCYTE; CELL CULTURE; FEMALE; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LEWIS RAT; MALE; PHENOTYPE; PHYSIOLOGY; RAT; REGULATORY T LYMPHOCYTE;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; FEMALE; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MALE; PHENOTYPE; RATS; RATS, INBRED LEW; T-LYMPHOCYTES, REGULATORY;

EID: 79952201743     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-60761-869-0_5     Document Type: Chapter

References (54)

1. Gershon, R.K. and Kondo, K. 1971. Infectious immunological tolerance. Immunology 21:903–914.
2. Cantor, H., Shen, F.W., and Boyse, E.A. 1976. Separation of helper T cells from suppressor T cells expressing different Ly components. II. Activation by antigen: after immunization, antigen-specific suppressor and helper activities are mediated by distinct T-cell subclasses. J Exp Med 143: 1391–1340.
3. Thomas, Y., Rogozinski, L., Rabbani, L., Chess, A., Goldstein, G., and Chess, L. 1984. Functional analysis of human T cell subsets defined by monoclonal antibodies. VI. Distinct and opposing immunoregulatory functions within the OKT8+ population. J Mol Cell Immunol 1:103–113.
4. Emara, M., Miceli, M.C., Finn, O.J., and Sanfilippo, F. 1988. Human suppressor T cells induced in vitro with an autologous renal allograft-derived T cell line. I. Suppressor cell induction, function, and specificity. Hum Immunol 23:223–240.
5. Sindhi, R., Manavalan, J.S., Magill, A., Suciu-Foca, N., and Zeevi, A. 2005. Reduced immunosuppression in pediatric liver-intestine transplant recipients with CD8+CD28− T-suppressor cells. Hum Immunol 66:252–257.
6. Colovai, A.I., Mirza, M., Vlad, G., Wang, S., Ho, E., Cortesini, R., and Suciu-Foca, N. 2003. Regulatory CD8+CD28− T cells in heart transplant recipients. Hum Immunol 64:31–37.
7. Manavalan, J.S., Kim-Schulze, S., Scotto, L., Naiyer, A.J., Vlad, G., Colombo, P.C., Marboe, C., Mancini, D., Cortesini, R., and Suciu-Foca, N. 2004. Alloantigen specific CD8+CD28− FOXP3+ T suppressor cells induce ILT3+ ILT4+ tolerogenic endothelial cells, inhibiting alloreactivity. Int Immunol 16:1055–1068.
8. Ciubotariu, R., Vasilescu, R., Ho, E., Cinti, P., Cancedda, C., Poli, L., Late, M., Liu, Z., Berloco, P., Cortesini, R., et al. 2001. Detection of T suppressor cells in patients with organ allografts. Hum Immunol 62:15–20.
9. Trzonkowski, P., Zilvetti, M., Chapman, S., Wieckiewicz, J., Sutherland, A., Friend, P., and Wood, K.J. 2008. Homeostatic repopulation by CD28−CD8+ T cells in alemtuzumab-depleted kidney transplant recipients treated with reduced immunosuppression. Am J Transplant 8:338–347.
10. Dijke, I.E., Caliskan, K., Klepper, M., de Kuiper, R., Balk, A.H., Maat, A.P., Weimar, W., and Baan, C.C. 2009. Donor-specific immune regulation by CD8 lymphocytes expanded from rejecting human cardiac allografts. Am J Transplant 9:397–403.
11. Guillonneau, C., Hill, M., Hubert, F.X., Chiffoleau, E., Herve, C., Li, X.L., Heslan, M., Usal, C., Tesson, L., Menoret, S., et al. 2007. CD40Ig treatment results in allograft acceptance mediated by CD8CD45RC T cells, IFN-gamma, and indoleamine 2,3-dioxyge-nase. J Clin Invest 117:1096–1106.
12. Jiang, H., Zhang, S.I., and Pernis, B. 1992. Role of CD8+ T cells in murine experimental allergic encephalomyelitis. Science 256: 1213–1215.
13. Koh, D.R., Fung-Leung, W.P., Ho, A., Gray, D., Acha-Orbea, H., and Mak, T.W. 1992. Less mortality but more relapses in experimental allergic encephalomyelitis in CD8−/− mice. Science 256:1210–1213.
14. Penninger, J.M., Neu, N., Timms, E., Wallace, V.A., Koh, D.R., Kishihara, K., Pummerer, C., and Mak, T.W. 1993. The induction of experimental autoimmune myocarditis in mice lacking CD4 or CD8 molecules (corrected). J Exp Med 178:1837–1842.
15. Tada, Y., Ho, A., Koh, D.R., and Mak, T.W. 1996. Collagen-induced arthritis in CD4-or CD8-deficient mice: CD8+ T cells play a role in initiation and regulate recovery phase of collagen-induced arthritis. J Immunol 156: 4520–4526.
16. Brimnes, J., Allez, M., Dotan, I., Shao, L., Nakazawa, A., and Mayer, L. 2005. Defects in CD8+ regulatory T cells in the lamina propria of patients with inflammatory bowel disease. J Immunol 174:5814–5822.
17. Tennakoon, D.K., Mehta, R.S., Ortega, S.B., Bhoj, V., Racke, M.K., and Karandikar, N.J. 2006. Therapeutic induction of regulatory, cytotoxic CD8+ T cells in multiple sclerosis. J Immunol 176:7119–7129.
18. Suzuki, M., Konya, C., Goronzy, J.J., and Weyand, C.M. 2008. Inhibitory CD8+ T cells in autoimmune disease. Hum Immunol 69: 781–789.
19. Vlad, G. and Suciu-Foca, N. 2008. Resurgence or emergence of CD8+ Ts. Hum Immunol 69:679–680.
20. Niederkorn, J.Y. 2008. Emerging concepts in CD8(+) T regulatory cells. Curr Opin Immunol 20:327–331.
21. Collison, L.W., Pillai, M.R., Chaturvedi, V., and Vignali, D.A. 2009. Regulatory T cell suppression is potentiated by target T cells in a cell contact, IL-35-and IL-10-dependent manner. J Immunol 182:6121–6128.
22. Bisikirska, B., Colgan, J., Luban, J., Bluestone, J.A., and Herold, K.C. 2005. TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs. J Clin Invest 115:2904–2913.
23. Billerbeck, E., Blum, H.E., and Thimme, R. 2007. Parallel expansion of human virus-specific FoxP3− effector memory and de novo-generated FoxP3+ regulatory CD8+ T cells upon antigen recognition in vitro. J Immunol 179:1039–1048.
24. Joosten, S.A., van Meijgaarden, K.E., Savage, N.D., de Boer, T., Triebel, F., van der Wal, A., de Heer, E., Klein, M.R., Geluk, A., and Ottenhoff, T.H. 2007. Identification of a human CD8+ regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4. Proc Natl Acad Sci U S A 104:8029–8034.
25. Wei, S., Kryczek, I., Zou, L., Daniel, B., Cheng, P., Mottram, P., Curiel, T., Lange, A., and Zou, W. 2005. Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma. Cancer Res 65: 5020–5026.
26. Gilliet, M. and Liu, Y.J. 2002. Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J Exp Med 195:695–704.
27. Ordonez, L., Bernard, I., L’Faqihi-Olive, F.E., Tervaert, J.W., Damoiseaux, J., and Saoudi, A. 2009. CD45RC isoform expression identifies functionally distinct T cell subsets differentially distributed between healthy individuals and AAV patients. PLoS One 4:e5287.
28. Dhodapkar, M.V. and Steinman, R.M. 2002. Antigen-bearing immature dendritic cells induce peptide-specific CD8(+) regulatory T cells in vivo in humans. Blood 100:174–177.
29. Cai, J., Lee, J., Jankowska-Gan, E., Derks, R., Pool, J., Mutis, T., Goulmy, E., and Burlingham, W.J. 2004. Minor H antigen HA-1-specific regulator and effector CD8+ T cells, and HA-1 microchimerism, in allograft tolerance. J Exp Med 199:1017–1023.
30. Siegmund, K., Ruckert, B., Ouaked, N., Burgler, S., Speiser, A., Akdis, C.A., and Schmidt-Weber, C.B. 2009. Unique phenotype of human tonsillar and in vitro-induced FOXP3+CD8+ T cells. J Immunol 182: 2124–2130.
31. Zheng, J., Liu, Y., Qin, G., Chan, P.L., Mao, H., Lam, K.T., Lewis, D.B., Lau, Y.L., and Tu, W. 2009. Efficient induction and expansion of human alloantigen-specific CD8 regulatory T cells from naive precursors by CD40-activated B cells. J Immunol 183:3742–3750.
32. Uss, E., Rowshani, A.T., Hooibrink, B., Lardy, N.M., van Lier, R.A., and ten Berge, I.J. 2006. CD103 is a marker for alloantigen-induced regulatory CD8+ T cells. J Immunol 177: 2775–2783.
33. Myers, L., Croft, M., Kwon, B.S., Mittler, R.S., and Vella, A.T. 2005. Peptide-specific CD8 T regulatory cells use IFN-gamma to elaborate TGF-beta-based suppression. J Immunol 174:7625–7632.
34. Noble, A., Giorgini, A., and Leggat, J.A. 2006. Cytokine-induced IL-10-secreting CD8 T cells represent a phenotypically distinct suppressor T-cell lineage. Blood 107:4475–4483.
35. Bienvenu, B., Martin, B., Auffray, C., Cordier, C., Becourt, C., and Lucas, B. 2005. Peripheral CD8+CD25+ T lymphocytes from MHC class II-deficient mice exhibit regulatory activity. J Immunol 175:246–253.
36. Sugita, S., Futagami, Y., Horie, S., and Mochizuki, M. 2007. Transforming growth factor beta-producing Foxp3(+)CD8(+) CD25(+) T cells induced by iris pigment epithelial cells display regulatory phenotype and acquire regulatory functions. Exp Eye Res 85:626–636.
37. Menager-Marcq, I., Pomie, C., Romagnoli, P., and van Meerwijk, J.P. 2006. CD8(+)CD28(−) Regulatory T lymphocytes prevent experimental inflammatory bowel disease in mice. Gastroenterology 131:1775–1785.
38. Hahn, B.H., Singh, R.P., La Cava, A., and Ebling, F.M. 2005. Tolerogenic treatment of lupus mice with consensus peptide induces Foxp3-expressing, apoptosis-resistant, TGFbeta-secreting CD8+ T cell suppressors. J Immunol 175:7728–7737.
39. Rifa’i, M., Kawamoto, Y., Nakashima, I., and Suzuki, H. 2004. Essential roles of CD8+CD122+ regulatory T cells in the maintenance of T cell homeostasis. J Exp Med 200:1123–1134.
40. Endharti, A.T., Rifa’I, M., Shi, Z., Fukuoka, Y., Nakahara, Y., Kawamoto, Y., Takeda, K., Isobe, K., and Suzuki, H. 2005. Cutting edge: CD8+CD122+ regulatory T cells produce IL-10 to suppress IFN-gamma production and proliferation of CD8+ T cells. J Immunol 175:7093–7097.
41. Chen, X., Priatel, J.J., Chow, M.T., and Teh, H.S. 2008. Preferential development of CD4 and CD8 T regulatory cells in RasGRP1-deficient mice. J Immunol 180:5973–5982.
42. Izawa, A., Yamaura, K., Albin, M.J., Jurewicz, M., Tanaka, K., Clarkson, M.R., Ueno, T., Habicht, A., Freeman, G.J., Yagita, H., et al. 2007. A novel alloantigen-specific CD8+PD1+ regulator y T cell induced by ICOS-B7h blockade in vivo. J Immunol 179: 786–796.
43. Ju, S.A., Park, S.M., Lee, S.C., Kwon, B.S., and Kim, B.S. 2007. Marked expansion of CD11c+CD8+ T-cells in melanoma-bearing mice induced by anti-4-1BB monoclonal antibody. Mol Cells 24:132–138.
44. Seo, S.K., Choi, J.H., Kim, Y.H., Kang, W.J., Park, H.Y., Suh, J.H., Choi, B.K., Vinay, D.S., and Kwon, B.S. 2004. 4-1BB-mediated immunotherapy of rheumatoid arthritis. Nat Med 10:1088–1094.
45. Hu, D., Ikizawa, K., Lu, L., Sanchirico, M.E., Shinohara, M.L., and Cantor, H. 2004. Analysis of regulatory CD8 T cells in Qa-1-deficient mice. Nat Immunol 5:516–523.
46. Ho, J., Kurtz, C.C., Naganuma, M., Ernst, P.B., Cominelli, F., and Rivera-Nieves, J. 2008. A CD8+/CD103high T cell subset regulates TNF-mediated chronic murine ileitis. J Immunol 180:2573–2580.
47. Wang, J., Jiang, S., Shi, H., Lin, Y., Wang, J., and Wang, X. 2008. Prolongation of corneal xenotransplant survival by T-cell vaccination-induced T-regulatory cells. Xenotransplantation 15:164–173.
48. Liu, Y., Chen, N., Chen, G., and You, P. 2007. The protective effect of CD8+CD28− T suppressor cells on the acute rejection responses in rat liver transplantation. Transplant Proc 39:3396–3403.
49. Zhou, J., Carr, R.I., Liwski, R.S., Stadnyk, A.W., and Lee, T.D. 2001. Oral exposure to alloantigen generates intragraft CD8+ regulatory cells. J Immunol 167:107–113.
50. Xystrakis, E., Dejean, A.S., Bernard, I., Druet, P., Liblau, R., Gonzalez-Dunia, D., and Saoudi, A. 2004. Identification of a novel natural regulatory CD8 T-cell subset and analysis of its mechanism of regulation. Blood 104:3294–3301.
51. Han, G., Shao, H., Peng, Y., Zhang, P., Ke, Y., Kaplan, H.J., and Sun, D. 2007. Suppressor role of rat CD8+CD45RClow T cells in experimental autoimmune uveitis (EAU). J Neuroimmunol 183:81–88.
52. Oluwole, S.F., Ng, A.K., Reemtsma, K., and Hardy, M.A. 1989. The mechanism of the induction of immunologic unrespon-siveness to rat cardiac allografts by recipient pretreatment with donor lymphocyte subsets. Transplantation 48:281–288.
53. Kataoka, M., Margenthaler, J.A., Ku, G., and Flye, M.W. 2003. Development of infectious tolerance after donor-specific transfusion and rat heart transplantation. J Immunol 171:204–211.
54. Miller, A., Lider, O., and Weiner, H.L. 1991. Antigen-driven bystander suppression after oral administration of antigens. J Exp Med 174:791–798.